We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
1526
Nutanix
NTNX
$16.9B
$85K 0.01%
3,790
+3,523
+1,319% +$77.1K
TTI icon
1527
TETRA Technologies
TTI
$1.26B
$85K 0.01%
+29,653
New +$72.7K
EGIO
1528
DELISTED
Edgio, Inc. Common Stock
EGIO
$85K 0.01%
+533
New +$74.9K
ALTA
1529
DELISTED
Altabancorp
ALTA
$85K 0.01%
+2,641
New +$73.6K
TYPE
1530
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$85K 0.01%
+4,423
New +$82.8K
BEL
1531
DELISTED
Belmond Ltd.
BEL
$85K 0.01%
+6,273
New +$80.6K
IPXL
1532
DELISTED
Impax Laboratories, Inc.
IPXL
$85K 0.01%
+4,170
New +$79.7K
CHCT
1533
Community Healthcare Trust
CHCT
$454M
$84K 0.01%
+3,082
New +$79.4K
TDAY
1534
USA Today Co
TDAY
$1.06B
$84K 0.01%
+5,657
New +$77.7K
GNTY
1535
DELISTED
Guaranty Bancshares
GNTY
$84K 0.01%
+2,880
New +$80.8K
MOD icon
1536
Modine Manufacturing
MOD
$10.4B
$84K 0.01%
+4,378
New +$73.4K
STLA icon
1537
Stellantis
STLA
$20.8B
$84K 0.01%
4,678
+3,574
+324% +$49.4K
BOLD
1538
DELISTED
Audentes Therapeutics, Inc
BOLD
$84K 0.01%
2,985
+2,881
+2,770% +$62.6K
AEP icon
1539
American Electric Power
AEP
$68.4B
$83K 0.01%
1,184
-196
-14% -$14K
BANC icon
1540
Banc of California
BANC
$2.97B
$83K 0.01%
+4,021
New +$79.3K
DDD icon
1541
3D Systems Corp
DDD
$613M
$83K 0.01%
+6,207
New +$90.9K
FARO
1542
DELISTED
Faro Technologies
FARO
$83K 0.01%
2,186
+1,826
+507% +$66.1K
FBNC icon
1543
First Bancorp
FBNC
$2.68B
$83K 0.01%
2,409
+2,209
+1,105% +$69.3K
IVE icon
1544
iShares S&P 500 Value ETF
IVE
$49.8B
$83K 0.01%
775
-26,729
-97% -$2.83M
KMPR icon
1545
Kemper
KMPR
$1.68B
$83K 0.01%
+1,557
New +$71K
TRST
1546
Trustco Bank Corp NY
TRST
$938M
$83K 0.01%
1,864
+1,664
+832% +$66.4K
UHT
1547
Universal Health Realty Income Trust
UHT
$594M
$83K 0.01%
+1,104
New +$85.1K
WSR
1548
DELISTED
Whitestone REIT
WSR
$83K 0.01%
+6,334
New +$81K
YORW icon
1549
York Water
YORW
$514M
$83K 0.01%
2,458
+1,049
+74% +$35.6K
AAMC
1550
DELISTED
Altisource Asset Management Corp
AAMC
$83K 0.01%
1,765
+1,114
+171% +$58.7K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.